The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmigo Regulatory News (AMGO)

Share Price Information for Amigo (AMGO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.25
Ask: 0.30
Change: 0.00 (0.00%)
Spread: 0.05 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
AMGO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Mar 2021 07:00

RNS Number : 5556R
Amigo Holdings PLC
09 March 2021
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Amigo Holdings PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

JPMorgan Chase & Co.

City and country of registered office (if applicable)

Wilmington, Delaware, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

J.P. Morgan Securities Plc

 

City and country of registered office (if applicable)

London, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

04 March 2021

6. Date on which issuer notified (DD/MM/YYYY):

08 March 2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuervii

Resulting situation on the date on which threshold was crossed or reached

6.87%

0.15%

7.02%

475,333,760

Position of previous notification (if

applicable)

6.41%

0.58%

6.99%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BFFK8T45

32,672,123

6.87%

SUBTOTAL 8. A

32,672,123

6.87%

 

 

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

Cash-settled Equity Swap

06/04/2021

06/04/2021

Cash

9,022

0.00%

Cash-settled Equity Swap

02/07/2021

02/07/2021

Cash

18,095

0.00%

Cash-settled Equity Swap

03/08/2021

03/08/2021

Cash

270

0.00%

Cash-settled Equity Swap

02/11/2021

02/11/2021

Cash

3,911

0.00%

Cash-settled Equity Swap

02/12/2021

02/12/2021

Cash

10,190

0.00%

Cash-settled Equity Swap

05/01/2022

05/01/2022

Cash

15,278

0.00%

Cash-settled Equity Swap

02/02/2022

02/02/2022

Cash

24,742

0.01%

Cash-settled Equity Swap

02/03/2022

02/03/2022

Cash

97,748

0.02%

Cash-settled Equity Swap

04/04/2022

04/04/2022

Cash

86,595

0.02%

Cash-settled Equity Swap

04/05/2022

04/05/2022

Cash

222,427

0.05%

Cash-settled Equity Swap

28/01/2026

28/01/2026

Cash

209,358

0.04%

SUBTOTAL 8.B.2

697,636

0.15%

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association

J.P. Morgan International Finance Limited

J.P. Morgan Capital Holdings Limited

J.P. Morgan Securities plc

6.87%

7.02%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

 N/A

11. Additional informationxvi

 

Chain of controlled undertakings:

 

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities plc (100%)

 

 

Place of completion

London, United Kingdom

Date of completion

08 March 2021

 

 

 

Notes

 

i Please note this form should be read jointly with the applicable Disclosure Guidance and Transparency Rules Chapter 5 (DTR5) available on the following link: https://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all parties to the agreement referred to in DTR5.2.1 (a) or (d) the holder of financial instruments referred to in DTR5.3.1.

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in DTR5.2.1 (b), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (c), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in DTR5.2.1 (d), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in DTR5.2.1 (e), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in DTR5.2.1 (g), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to DTR5.2 unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights held in the issuer shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold, please note that it might not be necessary to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only thus the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.).

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEANDPELEFEFA
Date   Source Headline
9th Apr 20247:00 amRNSGeneral Meeting
5th Apr 20248:05 amRNSAdmission of Shares
28th Mar 20247:00 amRNSAppointment of strategic consultant
18th Dec 20237:00 amRNSInterim Financial Results
14th Dec 20231:00 pmRNSNotice of Results
30th Nov 20232:00 pmRNSBoard and Company Secretary Change
20th Nov 20233:15 pmRNSStandard form for notification of major holdings
17th Nov 20238:39 amRNSListing Restoration & Resumption of Share Trading
17th Nov 20238:05 amRNSListing Restoration & Resumption of Share Trading
17th Nov 20237:00 amRNSStandard form for notification of major holdings
16th Nov 20237:00 amRNSTermination of Potential Transaction
17th Oct 20237:43 amRNSProposed transaction and suspension of listing
17th Oct 20237:30 amRNSSuspension - Amigo Holdings PLC
27th Sep 20233:30 pmRNSResult of AGM
27th Sep 20237:00 amRNSAGM Statement
4th Sep 20233:55 pmRNSNotice of AGM
14th Aug 20235:00 pmRNSAnnual Report and Accounts
27th Jul 20237:00 amRNSFinancial Results for the year ended 31 March 2023
15th Jun 20232:18 pmRNSChange of Registered Office
9th Jun 20237:00 amRNSMarket Update
16th May 20237:00 amRNSBoard change
19th Apr 20237:00 amRNSStatement re. share price movement
3rd Apr 20237:00 amRNSEmployee Share Schemes & Total Voting Rights
3rd Apr 20237:00 amRNSUpdate on Senior Secured Loan Notes
30th Mar 20234:40 pmRNSSecond Price Monitoring Extn
30th Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20233:22 pmRNSUpdate on corporate broker
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20234:40 pmRNSSecond Price Monitoring Extn
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20231:15 pmRNSBoard changes
23rd Mar 20237:01 amRNSScheme of Arrangement Update
13th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20237:36 amRNSUpdate on Capital Raise and Scheme of Arrangement
10th Mar 20237:00 amRNSShare Incentive Plan purchase
9th Mar 20234:40 pmRNSSecond Price Monitoring Extn
9th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSGeneral Meeting Statement
7th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20234:35 pmRNSPrice Monitoring Extension
27th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNS3rd Quarter Results
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSNotice of General Meeting
14th Feb 20237:14 amRNSStatement re Conclusion of Enforcement Action

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.